Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples. 2010

Jared M Baeten, and Deborah Donnell, and Saidi H Kapiga, and Allan Ronald, and Grace John-Stewart, and Mubiana Inambao, and Rachel Manongi, and Bellington Vwalika, and Connie Celum, and
University of Washington, WA, USA. jbaeten@u.washington.edu

OBJECTIVE Male circumcision reduces female-to-male HIV-1 transmission risk by approximately 60%. Data assessing the effect of circumcision on male-to-female HIV-1 transmission are conflicting, with one observational study among HIV-1-serodiscordant couples showing reduced transmission but a randomized trial suggesting no short-term benefit of circumcision. METHODS Data collected as part of a prospective study among African HIV-1-serodiscordant couples were analyzed for the relationship between circumcision status of HIV-1-seropositive men and risk of HIV-1 acquisition among their female partners. Circumcision status was determined by physical examination. Cox proportional hazards analysis was used. RESULTS A total of 1096 HIV-1-serodiscordant couples in which the male partner was HIV-1-infected were followed for a median of 18 months; 374 (34%) male partners were circumcised. Sixty-four female partners seroconverted to HIV-1 (incidence 3.8 per 100 person-years). Circumcision of the male partner was associated with a nonstatistically significant approximately 40% lower risk of HIV-1 acquisition by the female partner (hazard ratio 0.62, 95% confidence interval 0.35-1.10, P = 0.10). The magnitude of this effect was similar when restricted to the subset of HIV-1 transmission events confirmed by viral sequencing to have occurred within the partnership (n = 50, hazard ratio 0.57, P = 0.11), after adjustment for male partner plasma HIV-1 concentrations (hazard ratio 0.60, P = 0.13), and when excluding follow-up time for male partners who initiated antiretroviral therapy (hazard ratio 0.53, P = 0.07). CONCLUSIONS Among HIV-1-serodiscordant couples in which the HIV-1-seropositive partner was male, we observed no increased risk and potentially decreased risk from circumcision on male-to-female transmission of HIV-1.

UI MeSH Term Description Entries
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002944 Circumcision, Male Excision of the prepuce of the penis (FORESKIN) or part of it. Male Circumcision,Circumcisions, Male,Male Circumcisions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D012725 Sexual Behavior Sexual activities of humans. Anal Sex,Oral Sex,Sexual Activity,Sexual Orientation,Premarital Sex Behavior,Sex Behavior,Sex Orientation,Sexual Activities,Activities, Sexual,Activity, Sexual,Behavior, Premarital Sex,Behavior, Sex,Behavior, Sexual,Orientation, Sexual,Sex, Anal,Sex, Oral
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015498 HIV-2 An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker. HTLV-IV,Human T-Lymphotropic Virus Type IV,Human immunodeficiency virus 2,LAV-2,HIV-II,Human Immunodeficiency Virus Type 2,Human T Lymphotropic Virus Type IV,Immunodeficiency Virus Type 2, Human,SBL-6669

Related Publications

Jared M Baeten, and Deborah Donnell, and Saidi H Kapiga, and Allan Ronald, and Grace John-Stewart, and Mubiana Inambao, and Rachel Manongi, and Bellington Vwalika, and Connie Celum, and
November 2014, The Lancet. Global health,
Jared M Baeten, and Deborah Donnell, and Saidi H Kapiga, and Allan Ronald, and Grace John-Stewart, and Mubiana Inambao, and Rachel Manongi, and Bellington Vwalika, and Connie Celum, and
February 2015, Journal of acquired immune deficiency syndromes (1999),
Jared M Baeten, and Deborah Donnell, and Saidi H Kapiga, and Allan Ronald, and Grace John-Stewart, and Mubiana Inambao, and Rachel Manongi, and Bellington Vwalika, and Connie Celum, and
August 2018, The lancet. HIV,
Jared M Baeten, and Deborah Donnell, and Saidi H Kapiga, and Allan Ronald, and Grace John-Stewart, and Mubiana Inambao, and Rachel Manongi, and Bellington Vwalika, and Connie Celum, and
January 2014, Archives of sexual behavior,
Jared M Baeten, and Deborah Donnell, and Saidi H Kapiga, and Allan Ronald, and Grace John-Stewart, and Mubiana Inambao, and Rachel Manongi, and Bellington Vwalika, and Connie Celum, and
May 2010, BMJ (Clinical research ed.),
Jared M Baeten, and Deborah Donnell, and Saidi H Kapiga, and Allan Ronald, and Grace John-Stewart, and Mubiana Inambao, and Rachel Manongi, and Bellington Vwalika, and Connie Celum, and
September 2015, Revista brasileira de epidemiologia = Brazilian journal of epidemiology,
Jared M Baeten, and Deborah Donnell, and Saidi H Kapiga, and Allan Ronald, and Grace John-Stewart, and Mubiana Inambao, and Rachel Manongi, and Bellington Vwalika, and Connie Celum, and
January 2011, PloS one,
Jared M Baeten, and Deborah Donnell, and Saidi H Kapiga, and Allan Ronald, and Grace John-Stewart, and Mubiana Inambao, and Rachel Manongi, and Bellington Vwalika, and Connie Celum, and
June 2005, Medecine et maladies infectieuses,
Jared M Baeten, and Deborah Donnell, and Saidi H Kapiga, and Allan Ronald, and Grace John-Stewart, and Mubiana Inambao, and Rachel Manongi, and Bellington Vwalika, and Connie Celum, and
September 2018, Medicine,
Jared M Baeten, and Deborah Donnell, and Saidi H Kapiga, and Allan Ronald, and Grace John-Stewart, and Mubiana Inambao, and Rachel Manongi, and Bellington Vwalika, and Connie Celum, and
January 2008, Antiviral therapy,
Copied contents to your clipboard!